Company: PGEN
Filing Date: 2025-08-19
Form Type: S-3
Source: 0000950103-25-010472
Chunk: 7

Company: PRECIGEN, INC.
Filing Date: 2025-08-19
Form: S-3
Chunk 7
---
 selling stockholders identified in this prospectus and, as applicable, their pledgees, assignees, transferees, distributees, donees, and successors-in-interest that may be identified in a prospectus supplement, a free writing prospectus or filings we make with the SEC under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are incorporated herein by reference. Selling Stockholders Overview This prospectus relates to the offering by selling stockholders of up to an aggregate of 143,809,489 shares of our Common Stock and up to an aggregate of 79,000 shares of our Preferred Stock. The Preferred Stock and Warrants that the Common Stock underly were issued to the selling stockholders on December 30, 2024 in connection with the Private Placement. The selling stockholders agreed pursuant to the terms of the Registration Rights Agreement dated as of December 30, 2024 entered into in connection with the Private Placement to cause us to use reasonable best efforts to register the resale of shares of our Common Stock underlying the Preferred Stock and Warrants and Preferred Stock issued in connection with the Private Placement.

<div align='center'>2

Risk Factors</div>

Investment in any securities offered pursuant
to this prospectus and any applicable prospectus supplement involves significant risks. You should carefully consider the risk factors
incorporated by reference to our annual report on Form 10-K for the year ended December 31, 2024, or the 2024 Annual Report, our quarterly
reports on Form 10-Q filed with the SEC on May 14, 2025 and August 12, 2025, and any subsequent reports we file with the SEC after the
date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent
filings under the Exchange Act, and the risk factors and other information contained in any applicable prospectus supplement before making
a decision about investing in our securities. The risks and uncertainties we have described are not the only ones we face. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, financial condition,
and results of operations. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered
securities.

Our ability to pay dividends on the Preferred Stock may be limited, and holders of our Preferred Stock will not receive voting rights as a result of dividend arrearages and